People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Biotechnology, Software / Tech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ziopharm Oncology Inc | — | Biotechnology | Series D+ | $368.8M | $804.5M | 2015 |
| QSpex Technologies Inc | — | Software / Tech | Series B | $90.2M | $30.5M | 2013 |
| Manhattan Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $59.5M | $850.1M | 2010 |
| Corino Therapeutics, Inc. | — | Biotechnology | Seed | $3.5M | $154.3M | 2017 |
Timothy McInerney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy McInerney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Weiss | 1 | 8 |
| Stephen Martin | 1 | 5 |
| Michael Weiser | 1 | 5 |
| Jay Moorin | 1 | 4 |
| Randal J. Kirk | 1 | 4 |
| Evan Melrose | 1 | 4 |
| NEIL HERSKOWITZ | 1 | 3 |
| Peter Barber | 1 | 2 |
| Murray Brennan | 1 | 2 |
| Douglas W. Pagan | 1 | 2 |
| William Anton | 1 | 2 |
| Martin Sutter | 1 | 2 |
| James Cannon | 1 | 2 |
| Elan Z. Ezickson | 1 | 2 |
| DAVID M. MAUNEY | 1 | 2 |
| Scott G. Braunstein | 1 | 2 |
| SEAN POWER | 1 | 2 |
| Martin P. Sutter | 1 | 2 |
| Caesar Belbel | 1 | 1 |
| Randal Kirk | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.